Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: A case report and review of cases treated with rituximab

Journal of Dermatology

Volumn 38, Issue 11, 2011, Pages 1084-1089

  Anan, Takashi ^a   Shimizu, Fumiaki ^a   Hatano, Yutaka ^a   Okamoto, Osamu ^a   Katagiri, Kazumoto ^a   Fujiwara, Sakuhei ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; FLUDARABINE; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NILOTINIB; PENTOSTATIN; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VINCRISTINE;

ACANTHOLYSIS; AGED; ALOPECIA; ALTERNARIOSIS; BIOPSY; BRONCHIOLITIS OBLITERANS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; CORNEA PERFORATION; CUTANEOUS ALTERNARIOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; KIDNEY DYSFUNCTION; LABORATORY TEST; LETTER; LEUKOCYTOSIS; LYMPHOCYTOMA; MUCOSA INFLAMMATION; PARANEOPLASTIC PEMPHIGUS; PLASMAPHERESIS; RASH;

AGED; ALTERNARIOSIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CORNEAL PERFORATION; DERMATOMYCOSES; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PARANEOPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES, OCULAR; PEMPHIGUS;

EID: 80355132298     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01192.x     Document Type: Letter

References (17)

1. Heizmann M, Itin P, Wernli M, et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab. Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001; 66: 142-144. (Pubitemid 32096630)
2. Borradori L, Lombardi T, Samson J, et al. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001; 137: 269-272. (Pubitemid 32240777)
3. Ahmed AR, Avram MM, Duncan LM,. Case records of the Massachusetts general hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions. N Engl J Med 2003; 349: 382-391.
4. Schadlow MB, Anhalt GJ, Sinha AA,. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. J Drugs Dermatol 2003; 2: 564-567.
5. Van Rossum MM, Verhaegen NT, Jonkman MF, et al. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Leuk Lymphoma 2004; 45: 2327-2332. (Pubitemid 39504330)
6. Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. J Eur Acad Dermatol Venereol 2006; 20: 69-74.
7. Cummins DL, Mimouni D, Tzu J, et al. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 2007; 56: 153-159. (Pubitemid 46016996)
8. Hoque SR, Black MM, Cliff S,. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy. Clin Exp Dermatol 2007; 32: 172-175. (Pubitemid 46233023)
9. Taintor AR, Leiferman KM, Hashimoto T, et al. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia. J Am Acad Dermatol 2007; 56: S73-S76. (Pubitemid 46552078)
10. Meijs M, Mekkes J, van Noesel C, et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. Int J Dermatol 2008; 47: 632-634. (Pubitemid 351676515)
11. Schierl M, Foedinger D, Geissler K, et al. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia. Eur J Dermatol 2008; 18: 717-718.
12. Eccersley LRJ, Hoffbrand AV, Rustin MHA, McNamara CJ,. Paraneoplastic pemphigus associated with systemic mastocytosis. Am J Hematol 2009; 84: 847-848.
13. Anhalt GJ,. Paraneoplastic pemphigus. Adv Dermatol 1997; 12: 77-96; discussion 97.
14. Nagel A, Hertl M, Eming R,. B-cell directed therapy for inflammatory skin diseases. J Invest Dermatol 2009; 129: 289-301.
15. Beele H, Claerhout I, Kestelyn P, et al. Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatology 2001; 202: 147-150. (Pubitemid 32337172)
16. Liesegang TJ, Kostick DA, Lookingbill DP,. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003; 139: 1083-1084. (Pubitemid 36994841)
17. Machet L, Jan V, Machet MC, et al. Cutaneous alternariosis: role of corticosteroid-induced cutaneous fragility. Dermatology 1996; 193: 342-344. (Pubitemid 27007583)